1.
Respiration
; 89(1): 62-5, 2015.
Artículo
en Inglés
| MEDLINE
| ID: mdl-25531296
RESUMEN
Diffuse alveolar hemorrhage (DAH) is a rare but devastating complication of systemic lupus erythematosus (SLE) with a high early mortality rate. DAH seldom occurs without active organ involvement. Recently, rituximab (RTX), a B cell-targeted therapy, has been reported to be effective for life-threatening autoimmune diseases. We describe a SLE patient who presented with acute respiratory failure due to DAH without other active organ involvement. This condition was dramatically improved with RTX without cyclophosphamide.
Asunto(s)
Hemorragia/tratamiento farmacológico , Factores Inmunológicos/uso terapéutico , Enfermedades Pulmonares/tratamiento farmacológico , Lupus Eritematoso Sistémico/tratamiento farmacológico , Rituximab/uso terapéutico , Adulto , Femenino , Hemorragia/etiología , Humanos , Enfermedades Pulmonares/etiología , Lupus Eritematoso Sistémico/complicaciones
2.
Gastrointest Endosc
; 65(2): 325-6; discussion 326, 2007 Feb.
Artículo
en Inglés
| MEDLINE
| ID: mdl-17258996